Kannaway, the subsidiary of Medical Marijuana, Inc., experienced a record-setting revenue month in September 2021. The manufacturing subsidiary for Medical Marijuana, Inc. also experienced its largest revenue month in the division’s history.
“When asked what the greatest opportunity for our company is, I always share that we aim to be the first truly global cannabis company, bringing cannabinoid-based products to global emerging markets, and Japan’s success is the perfect illustration of that vision in reality,” said Medical Marijuana, Inc. Chief Executive Officer Blake Schroeder. “The Asian market represents one of the largest growth opportunities for cannabis products. It is relatively untapped and our entrance just over two years ago easily positioned us with a first-mover advantage. Our products have been exceptionally well-received in the market and I look forward to continued expansion in the region.”
The company recently announced the launch of its operations in Hong Kong, a market that has historically had very limited access to cannabis-based products.
